The present studies investigated the in vivo expression of the p53 suppressor gene and protein product in response to acute cutaneous injury in swine, along with the parallel expression of the c-sis/PDGF-B mitogen and its receptor ,6 (PDGF-R fl). p53 expression was shown to be suppressed during the period of active cellular proliferation in the injured tissue and to reemerge during the stages of healing. In contrast, c-sis/PDGF-B and PDGF-R ,6 were expressed during the early phase of active cellular proliferation and they were suppressed upon healing. This inverse relationship between mitogenic growth factors and p53 suggests the presence ofwell-controlled physiologic mechanisms that regulate in vivo the processes of normal tissue repair in response to injury. At the stages of tissue regeneration, these mechanisms include both the expression of growth factors that promote cell proliferation and the suppression of p53 that downregulates proliferation. At the stages of healing, the expression of the mitogenic growth factors is suppressed and that of p53 reemerges, reaching its peak at the time of complete epithelialization and healing of the injured tissue. These studies are the first to link the response of p53 protein to physiologic processes of tissue regeneration in vivo. (J. Clin. Invest. 1994. 93:2206-2214
Introduction
In vivo studies suggest that normal tissue regeneration after injury is mediated by the localized expression of several mitogenic growth factors and growth factor receptors at the site of injury (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . This localized expression of mitogenic growth factors and their receptors after injury seems to contribute to the complex processes involved in tissue regeneration. The expression levels induced by cutaneous injury were shown to be maximal during the stages ofactive tissue repair, declining and suppressed upon the healing of the wound (10, 12) . This controlled reversible expression of growth factors and their receptors in response to injury suggests that molecular mechanisms can be activated at the cellular level that contribute to the in-duction of gene expression in response to cellular injury, and the suppression of these genes upon healing.
In the present studies, we have investigated the expression ofp53 mRNA and its protein product in skin biopsy specimens from healthy swine before and after acute cutaneous injury. P53 expression seen in these studies represents the wild-type form present in normal, non-malignant tissue. The p53 mRNA and protein expression in the biopsy specimens was compared with the parallel expression, in the same specimens, of a mitogenic growth factor, the PDGF-B (c-sis/PDGF-B) mRNA and its receptor 1 (PDGF-R 3)1 mRNA and their respective protein products (for a review on PDGF, see reference 13). The p53 gene is located in the short arm of human chromosome 17 , and it encodes a 393-amino acid nuclear phosphoprotein (14) . The wild type p53 protein is a tumor suppressor, and this function results from its ability to arrest cell cycle progression (15) (16) (17) (18) (19) (20) (21) . This effect of wild type p53 on the cell cycle appears to be mediated by transcriptional transactivation (22) (23) (24) (25) (26) (27) (28) (29) (30) and transcriptional suppression (31) (32) (33) (34) (35) of genes that are involved in the control of cellular growth (for recent reviews, see references [36] [37] [38] . A role of p53 in DNA repair has been reported (39, 40) .
Because of these functional roles, we have investigated the response ofp53 to cellular injury in vivo to examine the following: a possible correlation between the levels of p53 expression and the proliferative state that characterizes normal tissue repair after injury; and a possible correlation between p53 expression and the expression of mitogenic growth factors and receptors (PDGF-B, PDGF-R 13) in response to injury and their suppression in response to healing.
In the present investigations, mRNA and protein expression was established using in situ hybridization and immunohistochemistry, respectively. These techniques allow not only demonstration of expression but they also enable the cellular localization of the expression. This permits a direct comparison of the expression of p53 in a given cell type with that of mitogenic growth factor genes and their receptors.
Methods
Collection ofskin biopsy specimens. Partial thickness wounds (10 X 15 mm) were surgically induced in the back ofyoung white Yorkshire pigs (10-15 kg) at a depth of 1.00 mm using a modified Castroviejo electrokeratome (Storz, St. Louis, MO; modified by Brownells, Montezuma, IA). Total excisional skin biopsy specimens were obtained from normal, uninjured skin before wounding (control), and at 1,3, and 6 h after wounding, and then daily for 5 d, and at 9 and 17 d after wounding. In this model, epithelialization of the injured tissue occurred at 5 d (41 tissue was performed using NTB2 (Eastman Kodak, Rochester, NY) and were developed and stained with hematoxylin and eosin at weekly intervals for 3 wk. Data presented here are from a 2-wk exposure. The specificity ofthe in situ hybridization was controlled by parallel hybridization ofserial tissue sections with control, noncomplementary (sense) riboprobes.
The antisense RNA probes used in these studies were for human wild type p53 (42) , human c-sis/PDGF-B (43), and mouse PDGF-R fi (44) .
RNA probes were prepared as described in H6fler et al. (45) using the Gemini II system (Promega Corp., Madison, WI). To test the integrity of the probes, 1 1u (2x106 cpm) of the probe was run on a 5.5% formaldehyde reducing gel, transferred onto a nytran membrane, and washed in water. The membrane was then exposed to an x-ray film for 1-3 h. The presence of a single transcript indicated that the probe was intact.
Immunocytochemistry. Protein expression in serial sections of the biopsy specimens were detected using the colloidal gold labeling technique (46) . For this purpose, the tissue sections (5 gm) were first incubated for 60 min at room temperature with specific primary antibodies to p53 (47, 48) (Fig. 1) . Epithelialization of the injured tissue in these studies is seen at -5 d after injury. As seen in Fig. 1 , on day 5, there is a significant reduction in the staining of the epithelial region. However, we have noticed that on days 5 and 9, staining can be seen in the basal epithelial layers of epithelial extensions within the dermis, suggesting an active ongoing process of epithelial tissue remodeling. Staining with the Ki-67 antibody is localized primarily in the nuclei of the cells with light staining present in the cytoplasm. Staining of serial tissue sections with control mouse IgG did not produce a significant expression (data not shown). p53 mRNA expression. As shown in Fig. 2 , p53 mRNA expression can be seen in the control, uninjured tissue. The mRNA expression is light, but it is uniformly present in the uninjured skin epithelial cells and in the underlying connective tissue cells. 1-6 h after injury, the expression remained unchanged, but it was completely suppressed on days 1 and 2 at the site of injury. Strong p53 mRNA expression can be seen again in the epithelial and connective tissue cells on day 3, and this expression declined progressively, reaching the control preinjury levels by days 9 and 17. Control hybridization of serial tissue sections with noncomplimentary riboprobe did not produce significant expression (data not shown).
p53 protein expression. The p53 mRNA expression seen in Fig. 2 was accompanied by the expression of its p53 protein product (Fig. 3) , as judged by the use of a specific monoclonal antibody (Pab-246) (47, 48) . Strong p53 protein expression can be seen in the epithelial and connective tissue cells ofthe uninjured control tissue and < 6 h after injury. In contrast, there is no significant p53 protein expression in biopsy specimens collected on days 1 and 2 after injury. This is consistent with the lack of p53 mRNA expression on the same specimens ( Figure  2 ). The suppression of p53 protein and mRNA expression in days 1 and 2 coincides with the state of active cell proliferation of the injured tissue as shown in Fig. 1 . p53 protein expression can be seen again on day 3 after injury, with a significant increase on day 5, and returning to control levels on days 9 and 17. The peak ofp53 protein expression seen on day 5 coincides with the timing of epithelialization of the injured tissue (41) . P53 protein expression is present primarily in the nuclei ofthe cells with some expression seen in the cytoplasm. Fig. 4 demonstrates the correlation between p53 protein expression and the proliferative activity of the epithelial cells at the site of injury, as judged by Ki-67 staining.
The suppression of the p53 mRNA and protein product seen on days 1 and 2 is confined only to the site of active proliferation of the injured tissue. Distant areas of intact uninjured epithelial and connective tissue cells in the biopsy specimens continued to express p53 mRNA and protein levels similar to those seen in the uninjured control tissue shown in Figs. 2 and 3 (data not shown).
Expression of c-sis/PDGF-B and PDGF-R 13 mRNAs and protein products. We compared the expression of p53 mRNA and its protein product to that of c-sis/PDGF-B and its receptor f3 (PDGF-R ,B) in the same biopsy specimens. As shown in Fig. 5 , there was no significant c-sis/PDGF-B or PDGF-R 3 mRNA expression in the epithelial and connective tissue cells of the control, uninjured tissue. A strong expression of PDGF-R [B mRNA can be seen within 6 h of injury. This expression increased progressively on days 1 and 2, it declined on day 5, and it was completely suppressed by day 9 after injury. 2210 Antoniades, Galanopoulos, Neville-Golden, Kiritsy, and Lynch Figure 5 . Examples of the expression of PDGF-R ft and c-sis/PDGF-B mRNAs before injury, and at 6 h and 3 d after injury. Notice the early strong expression of PDGF-R ,B mRNA 6 h after injury and the absence of PDGF-B expression in the same tissue specimen. x630.
There was no significant expression of c-sis/PDGF-B mRNA in the control uninjured tissue and at 6 h after injury. Expression ofc-sis/PDGF-B mRNA can be seen on day 1 after injury, it remained strong on days 2 and 3, it declined progressively on days 5 and 9, and it was totally suppressed by day 17 after injury.
The expression of the PDGF-R f3 mRNA preceded that of the c-sis/PDGF-B, and it was suppressed earlier than c-sis/ PDGF-B. However, both the c-sis/PDGF-B and its receptor mRNAs were strongly expressed during the stages of active cellular proliferation ofthe injured tissue. Their expression was accompanied by the expression oftheir respective protein products as shown in the examples presented in Fig. 6 . The data described above suggest an inverse relationship between the expression of c-sis/PDGF-B and its receptor and that of p53 expression. This inverse relationship is evident in Fig. 7, which sion does not parallel the intensity of its mRNA expression. For example, mRNA expression in the control specimen and at 6 h after injury is weak, but the protein expression is strong. Similarly, on day 3, mRNA intensity is higher than that seen on day 5, but the reverse is seen with the protein product (Fig. 7) .
Discussion
Normal tissue repair is characterized by an active proliferative state that contributes to the healing of the injured tissue. This proliferation process is stimulated by the localized expression of selective growth factors and receptors (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) that promote tissue regeneration. In the examples presented here, expression of PDGF-R ,3 occurred within 6 h of injury, and that of the PDGF-B mitogen within 1 d of injury. Their expression increased progressively during the phase ofactive cellular proliferation, and it was suppressed upon the healing of the injured tissue (Fig. 7) . A similar response has been reported for other mitogenic growth factors such as TGF-a and its receptor, the EGF receptor, and acidic and basic fibroblast growth factors ( 12). Days after Injury In contrast, as shown here, the p53 protein expression was totally suppressed during the phase of active cellular proliferation after injury, and it reemerged during the period of the healing process (Fig. 4) . The expression ofp53 protein reached a peak on about day 5 after injury, which coincides with the time of epithelialization of the injured tissue in this in vivo model (41) . The suppression ofp53 during the active proliferative state is consistent with the antiproliferative role, attributed to wild type p53 protein (15) (16) (17) (18) (19) (20) (21) . Its suppression during this stage of proliferation after injury serves to remove an agent involved in negative cell growth. On the other hand, its strong expression at the time of epithelialization and healing may serve to downregulate the proliferative process. This is consistent with the finding that overexpression of wild type p53 inhibits cell proliferation by blocking the cells in the GI phase of the cell cycle (16, 19) .
It is apparent from the present data that during tissue regeneration, there is an inverse relationship between p53 expression and that ofthe c-sis/PDGF-B mitogen and its receptor (Fig. 7) . This inverse relationship between growth-promoting and growth-arresting factors suggests the presence of well-controlled in vivo mechanisms that regulate the physiologic processes ofnormal tissue regeneration. In pathologic proliferative disorders, there seems to be a disruption ofthis well-controlled balance between mitogenic growth factors that promote cellular proliferation and suppressor genes that contribute to the arrest ofcellular proliferation. There is strong evidence that the restraining function of wild type p53 protein is removed in malignancies through mutation-inactivation of the functional p53 protein (36, 38, 42, (50) (51) (52) (53) (54) . In these pathologic cases, the uncontrolled expression of mitogenic growth factors coupled with the inactivation of p53 protein will favor uncontrolled, pathologic cellular proliferation.
Wild-type P53 protein is a transcriptional transactivator (22) (23) (24) (25) (26) (27) (28) (29) (30) and also a transcriptional suppressor of several genes (31) (32) (33) (34) (35) , including c-fos (31, 33) and c-jun (31) . The presence of the TATA element in the promoter region ofgenes appears to be necessary for their suppression by the wild type p53 protein (35) . In the present studies, there is no evidence that p53 participates in the induction of the expression of c-sis/PDGF-B and PDGF-R mRNAs after injury. As shown above, during the induction of the expression of these genes, the levels of p53 protein remained either unchanged (6 h after injury) or were totally suppressed (days 1 and 2 after injury). On the other hand, it is possible that p53 protein contributes to the suppression ofthese genes during the healing process. At this stage, the p53 protein levels increased, while the c-sis/PDGF-B and PDGF-R levels kept declining and were totally suppressed upon the complete healing ofthe wound (Fig. 7) . Since there is no identifiable TATA element in c-sis/PDGF-B or PDGF-R b, it is conceivable that suppression ofthese genes by p53 in vivo, may involve indirect transcriptional transactivation of other genes, which in turn induces the suppression of the mitogenic genes.
In conclusion, normal tissue regeneration after injury includes the following molecular mechanisms: (a) selective localized expression of mitogenic growth factors that promote cell proliferation; (b) concomitant suppression of p53 which inhibits cell proliferation; (c) suppression ofthe mitogenic growth factors upon healing ofthe injured tissue; and (d) strong expression of p53, which serves to downregulate cellular growth during the stages of healing.
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